BModesto

Lelystad, Netherlands Founded: 2014 • Age: 12 yrs Acquired By Uniphar
Specializes in parallel import, brand holding, and exclusive distribution of pharmaceuticals.

About BModesto

BModesto is a Healthcare company based in Lelystad (Netherlands) founded in 2014, and was acquired by Uniphar in November 2022. It specializes in parallel import, brand holding, and exclusive distribution of pharmaceuticals. It operates on a B2B model. BModesto offers products and services including Parallel-Imported Medicines and Exclusive Distribution Services. Its focus areas include Pharmaceuticals, Wholesale and Parallel Import. Its legal entity is BModesto B.V. Its competitors include IDA Foundation, Daxtrio and Mach 2 Pharmafreight.

Company details

BModesto, based in Lelystad, Netherlands, operates as a pharmaceutical wholesaler focused on parallel import by sourcing medicines from EU countries with lower prices and supplying them to pharmacies and hospitals. They also serve as brand holders and exclusive distributors, ensuring a wide assortment of quality medicines at competitive rates. Their activities include marketing, reliable delivery, and maintaining optimal availability for healthcare providers.

  • Headquarters Lelystad, Netherlands
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bmodesto.com
  • Social LinkedIn
  • Acquired by Uniphar (Nov 2022)
  • Legal Name Bmodesto B.V.
Key Metrics

Products & Services of BModesto

BModesto offers a comprehensive portfolio of products and services, including Parallel-Imported Medicines and Exclusive Distribution Services.

Parallel-Imported Medicines
Pharmaceutical Products

Medicines sourced from EU for lower-cost distribution

Exclusive Distribution Services
Distribution Services

Marketing and distribution of specific pharmaceuticals

Investors in BModesto

BModesto has secured backing from 1 investor. Prominent investors backing the company include Uniphar.

All
InvestorDescriptionFounded YearDomainLocation
Speciality drugs are distributed throughout Ireland by Uniphar.
1967uniphar.ieDublin, Ireland
Premium access

Investor details for BModesto

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BModesto

9 people are tracked at BModesto (9 in team).

NameRoleGroup
Natalija Olthof
Commercieel Medewerker BinnendienstTeam
Maryam Talidi
Commericeel Medewerker BinnendienstTeam
Patrick Groeneveld
Manager Sales & PurchaseTeam
Jolanda De Rooij
Manager Verkoop BinnendienstTeam
Marco Seetz
Commercieel Medewerker BinnendienstTeam
Septi Visser
Commercieel Medewerker BinnendienstTeam
Laura MacKenzie
Demand PlannerTeam
Veron Lens
International Purchase Manager - Bij BmodestoTeam
Marciano Philippi
Supply Chain PlannerTeam
Premium access

Complete people profiles for BModesto

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BModesto

2 dated milestones of BModesto across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded BModesto is founded.
  2. Exit Acquired by Uniphar.

Competitors of BModesto

BModesto has 3 listed competitors in our database. They include IDA Foundation, Daxtrio and Mach 2 Pharmafreight.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
idafoundation.org1972Amsterdam, Netherlands91
Supplies essential medicines and medical goods to countries in need.
daxtrio.nl2007Zaandam, Netherlands
Medical supplies and equipment are supplied to primary care professionals.
mach2pharmafreight.com2019Haarlemmermeer, Netherlands
Provider of freight and distribution services for pharmaceutical products, setting industry standards
Premium access

Detailed competitors of BModesto

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bmodesto

Premium access

Complete news archive for BModesto

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BModesto

BModesto was founded in 2014.

BModesto is headquartered in Lelystad, Netherlands. It is registered at Lelystad, Flevoland, Netherlands.

BModesto, based in Lelystad, Netherlands, operates as a pharmaceutical wholesaler focused on parallel import by sourcing medicines from EU countries with lower prices and supplying them to pharmacies and hospitals. They also serve as brand holders and exclusive distributors, ensuring a wide assortment of quality medicines at competitive rates. Their activities include marketing, reliable delivery, and maintaining optimal availability for healthcare providers.

BModesto's top competitors include Mach 2 Pharmafreight, Daxtrio and IDA Foundation.

BModesto offers Parallel-Imported Medicines and Exclusive Distribution Services.

BModesto has 1 investor. Key investors include Uniphar.

BModesto operates through Bmodesto B.V..

Yes. BModesto was acquired by Uniphar in November 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available